Fiona Chionh

1.2k total citations
26 papers, 839 citations indexed

About

Fiona Chionh is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Fiona Chionh has authored 26 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Fiona Chionh's work include Colorectal Cancer Treatments and Studies (7 papers), Cancer Mechanisms and Therapy (5 papers) and Cancer Treatment and Pharmacology (4 papers). Fiona Chionh is often cited by papers focused on Colorectal Cancer Treatments and Studies (7 papers), Cancer Mechanisms and Therapy (5 papers) and Cancer Treatment and Pharmacology (4 papers). Fiona Chionh collaborates with scholars based in Australia, United States and Spain. Fiona Chionh's co-authors include John M. Mariadason, Niall C. Tebbutt, Laura J. Jenkins, Janson W.T. Tse, Matthias Ernst, Timothy Price, Merja Soilu‐Hänninen, Helmut Butzkueven, Ben Emery and Perry F. Bartlett and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Fiona Chionh

26 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fiona Chionh Australia	15	393	344	191	152	142	26	839
Jingyi Shi China	12	183 0.5×	536 1.6×	103 0.5×	78 0.5×	170 1.2×	32	1.1k
HuiYong Zhao United States	12	426 1.1×	584 1.7×	249 1.3×	165 1.1×	170 1.2×	18	1.1k
Adam J. Kole United States	9	268 0.7×	348 1.0×	59 0.3×	269 1.8×	425 3.0×	26	907
María Teresa Calvo Spain	12	235 0.6×	625 1.8×	210 1.1×	47 0.3×	84 0.6×	17	1.0k
Masayo Hosokawa Japan	15	252 0.6×	471 1.4×	49 0.3×	102 0.7×	133 0.9×	21	964
Qingjian Ou China	16	258 0.7×	575 1.7×	87 0.5×	169 1.1×	306 2.2×	81	1.1k
Heather J. Dalton United States	16	332 0.8×	424 1.2×	77 0.4×	107 0.7×	170 1.2×	29	990
Yuan Xiao Zhu United States	14	250 0.6×	855 2.5×	67 0.4×	45 0.3×	150 1.1×	26	1.1k
Gina Lama Italy	17	197 0.5×	286 0.8×	256 1.3×	187 1.2×	172 1.2×	27	931
Hiroki Odagiri Japan	16	393 1.0×	713 2.1×	69 0.4×	152 1.0×	161 1.1×	36	1.3k

Countries citing papers authored by Fiona Chionh

Since Specialization

Citations

This map shows the geographic impact of Fiona Chionh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Chionh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Chionh more than expected).

Fields of papers citing papers by Fiona Chionh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Chionh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Chionh. The network helps show where Fiona Chionh may publish in the future.

Co-authorship network of co-authors of Fiona Chionh

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Chionh. A scholar is included among the top collaborators of Fiona Chionh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Chionh. Fiona Chionh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jenkins, Laura J., Ian Y. Luk, Fiona Chionh, et al.. (2024). BCL-XL inhibitors enhance the apoptotic efficacy of BRAF inhibitors in BRAFV600E colorectal cancer. Cell Death and Disease. 15(3). 183–183. 4 indexed citations

Chionh, Fiona, Val Gebski, Sheren Al-Obaidi, et al.. (2022). VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer. Scientific Reports. 12(1). 1238–1238. 12 indexed citations

Luk, Ian Y., Laura J. Jenkins, Andrew Martin, et al.. (2021). Rapid Resistance of FGFR-driven Gastric Cancers to Regorafenib and Targeted FGFR Inhibitors can be Overcome by Parallel Inhibition of MEK. Molecular Cancer Therapeutics. 20(4). 704–715. 14 indexed citations

Mooi, Jennifer, Fiona Chionh, Peter Savas, et al.. (2021). Dual Antiangiogenesis Agents Bevacizumab Plus Trebananib, without Chemotherapy, in First-line Treatment of Metastatic Colorectal Cancer: Results of a Phase II Study. Clinical Cancer Research. 27(8). 2159–2167. 12 indexed citations

Hawkes, Eliza A., et al.. (2020). Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. Clinical Lymphoma Myeloma & Leukemia. 21(2). e179–e184. 5 indexed citations

Mouradov, Dmitri, Ian Y. Luk, David S. Williams, et al.. (2019). Genomic Profiling of Biliary Tract Cancer Cell Lines Reveals Molecular Subtypes and Actionable Drug Targets. iScience. 21. 624–637. 15 indexed citations

Tögel, Lars, Rui Wu, Anderly C. Chüeh, et al.. (2018). DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. Scientific Reports. 8(1). 1767–1767. 12 indexed citations

Tay, Rebecca, Fiona Chionh, Jennifer Mooi, et al.. (2018). Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. British Journal of Cancer. 118(7). 966–971. 35 indexed citations

Tse, Janson W.T., Laura J. Jenkins, Fiona Chionh, & John M. Mariadason. (2017). Aberrant DNA Methylation in Colorectal Cancer: What Should We Target?. Trends in cancer. 3(10). 698–712. 87 indexed citations

10.

Chionh, Fiona, Hoanh Tran, Janson W.T. Tse, et al.. (2017). K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. Molecular Oncology. 11(9). 1130–1142. 17 indexed citations

11.

Murphy, Cheryl, Eliza A. Hawkes, Fiona Chionh, & Geoffrey Chong. (2016). Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. Journal of Clinical Pharmacy and Therapeutics. 42(1). 111–114. 13 indexed citations

12.

Bazzocco, Sarah, Higinio Dopeso, Fernando Cartón‐García, et al.. (2015). Highly Expressed Genes in Rapidly Proliferating Tumor Cells as New Targets for Colorectal Cancer Treatment. Clinical Cancer Research. 21(16). 3695–3704. 30 indexed citations

13.

Weickhardt, Andrew, David S. Williams, Chee Khoon Lee, et al.. (2015). Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer. British Journal of Cancer. 113(1). 37–45. 47 indexed citations

14.

Shin, Joongho, Azadeh A. Carr, Georgia Corner, et al.. (2014). The Intestinal Epithelial Cell Differentiation Marker Intestinal Alkaline Phosphatase (ALPi) Is Selectively Induced by Histone Deacetylase Inhibitors (HDACi) in Colon Cancer Cells in a Kruppel-like Factor 5 (KLF5)-dependent Manner. Journal of Biological Chemistry. 289(36). 25306–25316. 48 indexed citations

15.

Andrews, Miles C., Andreas Behren, Fiona Chionh, et al.. (2013). BRAF Inhibitor–Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition. Journal of Clinical Oncology. 31(35). e448–e451. 44 indexed citations

16.

Chionh, Fiona, Gillian Mitchell, Geoffrey J. Lindeman, Michael Friedländer, & Clare L. Scott. (2011). The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: Current status and future directions. Asia-Pacific Journal of Clinical Oncology. 7(3). 197–211. 12 indexed citations

17.

Chionh, Fiona, Laura Baglietto, Kavitha Krishnan, et al.. (2010). Physical activity, body size and composition, and risk of ovarian cancer. Cancer Causes & Control. 21(12). 2183–2194. 28 indexed citations

18.

Azad, Arun, et al.. (2009). High Impact of 18F-FDG-PET on Management and Prognostic Stratification of Newly Diagnosed Small Cell Lung Cancer. Molecular Imaging and Biology. 12(4). 443–451. 40 indexed citations

19.

Chionh, Fiona, Kirsten Herbert, John F. Seymour, et al.. (2005). Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia. Leukemia & lymphoma. 46(4). 603–605. 3 indexed citations

20.

Butzkueven, Helmut, Jian‐Guo Zhang, Merja Soilu‐Hänninen, et al.. (2002). LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nature Medicine. 8(6). 613–619. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact